183P Identification of an antigen-presenting cells/T/NK cells-related gene signature to predict prognosis and gene marker CTSL to predict immunotherapeutic response for lung adenocarcinoma: An integrated analysis of bulk and single cell RNA sequencing

列线图 免疫系统 比例危险模型 小桶 免疫疗法 抗原 基因 生存分析 腺癌 西塔 医学 肿瘤科 计算生物学 生物 T细胞 免疫学 内科学 基因表达 癌症 转录组 遗传学 MHC II级
作者
L. Huang,T. Xie,Y. Shi
出处
期刊:Journal of Thoracic Oncology [Elsevier BV]
卷期号:18 (4): S140-S140
标识
DOI:10.1016/s1556-0864(23)00436-7
摘要

Background: Antigen-presenting cells (APC)/T/NK cells are key immune cells that play crucial roles in fighting against malignancies including lung adenocarcinoma (LUAD).In this study, we aimed to identify an APC/T/NK cell-related gene signature (ATNKGS) and potential immune marker genes (IMGs) to realize risk stratification, prognosis and immunotherapeutic response prediction for LUAD patients.Methods: Based on 196 antigen-presenting cells (APC)/T/NK cellsrelated genes collected from three pathways in the Kyoko encyclopedia of genes and genomes (KEGG) database, we determined the final genes and established the ATNKGS-related risk model via univariate Cox regression and LASSO Cox regression.Then we correlated ATNKGS with overall survival (OS), clinical characteristics, immune cell infiltration, and functional enrichment analysis of LUAD patients.The single cell RNA sequencing data was applied for identification of key IMGs and investigate their value in immunotherapeutic response prediction.Results: In this study, 8 independent public datasets including 1089 patients were enrolled.An ATNKGS containing 16 genes was constructed for prognostic prediction of overall survival in the TCGA discovery dataset.Its prognostic capability was verified by TCGA validation dataset and four other GEO datasets.A nomogram combining ATNKGS risk score and clinical TNM stage maximized the survival prediction of LUAD.The single cell RNA sequencing analysis revealed CTSL and HSPA6 as the key IMGs for monocyte and dendritic cells, respectively.Moreover, though CTSL was an indicator for poor prognosis of LUAD patients, CTSL high expression group was associated with higher ESTIMATEScore, immune checkpoints expression, and lower TIDE score.Several immunotherapeutic cohorts have confirmed the response-predicting significance of CTSL in patients receiving ICI treatment.Conclusions: In conclusion, our study provided an insight into the significant role of APC/T/NK cells-related genes in survival risk stratification and CTSL in response prediction of immunotherapy in patients with LUAD.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
3秒前
3秒前
3秒前
4秒前
劉jLJH发布了新的文献求助10
4秒前
4秒前
xxlw完成签到,获得积分10
5秒前
5秒前
susu发布了新的文献求助10
7秒前
高大曼云发布了新的文献求助10
7秒前
研究牲发布了新的文献求助10
8秒前
9秒前
Strawberry发布了新的文献求助10
9秒前
tiantian发布了新的文献求助10
9秒前
义气的青枫完成签到 ,获得积分10
9秒前
SciGPT应助11采纳,获得10
10秒前
11秒前
12秒前
正义的玉米完成签到 ,获得积分10
12秒前
斯文败类应助如意幻枫采纳,获得10
13秒前
伤心葫芦娃完成签到 ,获得积分10
13秒前
Akim应助CHUER采纳,获得10
13秒前
浮游应助你好好想想采纳,获得10
14秒前
sukasuka发布了新的文献求助10
14秒前
Ava应助哈哈采纳,获得10
15秒前
15秒前
tuanheqi应助科研通管家采纳,获得150
16秒前
科研通AI6应助科研通管家采纳,获得10
16秒前
Raven应助科研通管家采纳,获得100
17秒前
Akim应助科研通管家采纳,获得10
17秒前
Jasper应助科研通管家采纳,获得10
17秒前
天空之下发布了新的文献求助10
17秒前
领导范儿应助科研通管家采纳,获得10
17秒前
OU应助科研通管家采纳,获得10
17秒前
科研通AI6应助科研通管家采纳,获得10
17秒前
李爱国应助科研通管家采纳,获得10
17秒前
Ava应助sukasuka采纳,获得10
17秒前
科研通AI6应助科研通管家采纳,获得10
17秒前
Raven应助科研通管家采纳,获得10
17秒前
orixero应助科研通管家采纳,获得10
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Petrucci's General Chemistry: Principles and Modern Applications, 12th edition 600
FUNDAMENTAL STUDY OF ADAPTIVE CONTROL SYSTEMS 500
微纳米加工技术及其应用 500
Nanoelectronics and Information Technology: Advanced Electronic Materials and Novel Devices 500
Performance optimization of advanced vapor compression systems working with low-GWP refrigerants using numerical and experimental methods 500
Constitutional and Administrative Law 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 物理化学 基因 遗传学 催化作用 冶金 量子力学 光电子学
热门帖子
关注 科研通微信公众号,转发送积分 5300799
求助须知:如何正确求助?哪些是违规求助? 4448580
关于积分的说明 13846267
捐赠科研通 4334361
什么是DOI,文献DOI怎么找? 2379576
邀请新用户注册赠送积分活动 1374658
关于科研通互助平台的介绍 1340343